+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8f7z | ||||||
|---|---|---|---|---|---|---|---|
| Title | VRC34.01_mm28 bound to fusion peptide | ||||||
Components |
| ||||||
Keywords | VIRAL PROTEIN / FP-NEUTRALIZING ANTIBODY / FUSION PEPTIDE / HIV-1 / GLYCOPROTEIN / FP-TARGETING VACCINES | ||||||
| Biological species | Homo sapiens (human)![]() Human immunodeficiency virus 1 | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.7 Å | ||||||
Authors | Olia, A.S. / Kwong, P.D. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Nat Commun / Year: 2023Title: Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site. Authors: Bailey B Banach / Sergei Pletnev / Adam S Olia / Kai Xu / Baoshan Zhang / Reda Rawi / Tatsiana Bylund / Nicole A Doria-Rose / Thuy Duong Nguyen / Ahmed S Fahad / Myungjin Lee / Bob C Lin / ...Authors: Bailey B Banach / Sergei Pletnev / Adam S Olia / Kai Xu / Baoshan Zhang / Reda Rawi / Tatsiana Bylund / Nicole A Doria-Rose / Thuy Duong Nguyen / Ahmed S Fahad / Myungjin Lee / Bob C Lin / Tracy Liu / Mark K Louder / Bharat Madan / Krisha McKee / Sijy O'Dell / Mallika Sastry / Arne Schön / Natalie Bui / Chen-Hsiang Shen / Jacy R Wolfe / Gwo-Yu Chuang / John R Mascola / Peter D Kwong / Brandon J DeKosky / ![]() Abstract: The HIV-1 fusion peptide (FP) represents a promising vaccine target, but global FP sequence diversity among circulating strains has limited anti-FP antibodies to ~60% neutralization breadth. Here we ...The HIV-1 fusion peptide (FP) represents a promising vaccine target, but global FP sequence diversity among circulating strains has limited anti-FP antibodies to ~60% neutralization breadth. Here we evolve the FP-targeting antibody VRC34.01 in vitro to enhance FP-neutralization using site saturation mutagenesis and yeast display. Successive rounds of directed evolution by iterative selection of antibodies for binding to resistant HIV-1 strains establish a variant, VRC34.01_mm28, as a best-in-class antibody with 10-fold enhanced potency compared to the template antibody and ~80% breadth on a cross-clade 208-strain neutralization panel. Structural analyses demonstrate that the improved paratope expands the FP binding groove to accommodate diverse FP sequences of different lengths while also recognizing the HIV-1 Env backbone. These data reveal critical antibody features for enhanced neutralization breadth and potency against the FP site of vulnerability and accelerate clinical development of broad HIV-1 FP-targeting vaccines and therapeutics. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8f7z.cif.gz | 338.9 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8f7z.ent.gz | 271.1 KB | Display | PDB format |
| PDBx/mmJSON format | 8f7z.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 8f7z_validation.pdf.gz | 510.3 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 8f7z_full_validation.pdf.gz | 534.4 KB | Display | |
| Data in XML | 8f7z_validation.xml.gz | 63.3 KB | Display | |
| Data in CIF | 8f7z_validation.cif.gz | 86.9 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/f7/8f7z ftp://data.pdbj.org/pub/pdb/validation_reports/f7/8f7z | HTTPS FTP |
-Related structure data
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 | ![]()
| ||||||||
| 4 | ![]()
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein/peptide | Mass: 718.863 Da / Num. of mol.: 4 / Source method: obtained synthetically / Source: (synth.) ![]() Human immunodeficiency virus 1#2: Protein | Mass: 25091.197 Da / Num. of mol.: 4 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#3: Antibody | Mass: 23371.021 Da / Num. of mol.: 4 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#4: Water | ChemComp-HOH / | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.81 Å3/Da / Density % sol: 56.28 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, hanging drop / Details: 10% PEG 3350, 1.4M Na/K Phosphate pH 7.5 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 22-ID / Wavelength: 1 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Feb 10, 2022 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
| Reflection | Resolution: 2.7→50 Å / Num. obs: 60434 / % possible obs: 97.85 % / Redundancy: 6.5 % / CC1/2: 0.991 / CC star: 0.998 / Rmerge(I) obs: 0.134 / Rpim(I) all: 0.057 / Rrim(I) all: 0.146 / Net I/σ(I): 16 |
| Reflection shell | Resolution: 2.7→2.75 Å / Rmerge(I) obs: 0.581 / Mean I/σ(I) obs: 2.6 / Num. unique obs: 3015 / CC1/2: 0.844 / CC star: 0.957 / Rpim(I) all: 0.238 / Rrim(I) all: 0.629 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: Alphafold model Resolution: 2.7→36.22 Å / SU ML: 0.32 / Cross valid method: FREE R-VALUE / σ(F): 1.38 / Phase error: 24.13 / Stereochemistry target values: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.7→36.22 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
Human immunodeficiency virus 1
X-RAY DIFFRACTION
United States, 1items
Citation






PDBj








